Back

Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk of cancer therapy Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Maryam Al Qaseer

King Fahad Specialist Hospital, Dammam (Saudi Arabia)

5 More presentations in this session

Presentation thumbnail
Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
Doctor B. Huang (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.
Doctor F. Cribari (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth
Mr B. Van Berlo (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis
Doctor R. Gonzalez-Manzanares (Cordoba, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk of cancer therapy
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources